Table 3.
Indexes comparison between the young-age group and elder group before and after treatment in the observation group.
| Indexes | Before treatment | After treatment | ||||||
|---|---|---|---|---|---|---|---|---|
| Young-age group | Elder group | Z/t | P | Young-age group | Elder group | Z/t | P | |
| n = 26 | n = 45 | n = 26 | n = 45 | |||||
| ACT | 14.50 (11.75–15.00) | 13.00 (10.00–17.00) | 0.541 | 0.588 | 24.50 (20.00–27.00) | 26.00 (20.00–27.00) | 0.416 | 0.677 |
| VAS | 3.5 (3–5.25) | 4 (2–6) | 0.446 | 0.656 | 0.00 (0–1) | 0 (0–1) | 0.43 | 0.667 |
| FVC | 87.6 (80.00–99.25) | 90.3 (83.95–95.40) | 0.173 | 0.863 | 105.84 ± 9.67 | 102.99 ± 13.33 | 0.133 | 0.343a |
| FEV | 91.0 (79.88–100.88) | 88.70 (81.50–96.45) | 1.307 | 0.191 | 108.37 ± 12.13 | 104.30 ± 13.10 | 1.296 | 0.199a |
| FEF | 92.52 ± 9.32 | 91.61 ± 14.97 | 0.318 | 0.752a | 108.48 ± 9.15 | 104.84 ± 14.68 | 1.285 | 0.203a |
| FEF75 | 59.51 ± 22.19 | 55.58 ± 17.05 | 0.838 | 0.405a | 90.21 ± 26.06 | 90.47 ± 23.35 | 0.043 | 0.966a |
| FEF50 | 68.62 ± 14.96 | 66.76 ± 16.05 | 0.48 | 0.633a | 95.90 ± 21.16 | 90.98 ± 19.41 | 0.996 | 0.323a |
| FEF25 | 70.45 (60.58–81.15) | 65.30 (49.20–75.55) | 1.826 | 0.068 | 101.35 (88.60–107.55) | 97.60 (81.20–106.75) | 1.021 | 0.307 |
| MMEF75/MMEF25 | 68.28 ± 15.89 | 61.82 ± 16.40 | 1.617 | 0.110a | 97.10 (87.43–109.65) | 91.70 (69.65–101.40) | 1.414 | 0.157 |
| FeNO | 29.00 (23.00–48.25) | 33.00 (26.00–45.00) | 0.836 | 0.403 | 15.50 (10.00–27.25) | 16.00 (12.00–24.00) | 0.078 | 0.938 |
VAS, visual analog scale; FeNO, nitric oxide.
Student't-test. Mann–Whitney U-test is used for the rest.